Clinical trials: Portopulmonary Hypertension
Portopulmonary Hypertension
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
- Trial name
- PORTICO (NCT02382016)
- Testing
- Macitentan
- Where
- 52 sites in United States, Brazil and 5 more
- Volunteers
- 85 people
- Sponsor
- Actelion
Portopulmonary Hypertension, Pulmonary Arterial Hypertension
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
This was a multicenter, prospective, observational, open-label study. Patients meeting inclusion/exclusion criteria received treatment with treprostinil as recommended by their treating physicians and were followed according to…
- Conditions
- Portopulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension
- Trial name
- NCT01028651
- Testing
- Treprostinil
- Where
- 4 sites in United States
- Volunteers
- 13 people
- Sponsor
- United Therapeutics